Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Ventricular Assist Device Market Expected to Grow Between 2025 And 2029?

In recent years, the market size of the ventricular assist device has seen rapid expansion. It is projected to increase from $2.12 billion in 2024 to $2.37 billion in 2025, at a Compound Annual Growth Rate (CAGR) of 11.8%. The previous growth can be linked to a growing prevalence of heart failure and a surge in the need for organ transplantation procedures.

The market for ventricular assist devices is anticipated to experience substantial expansion in the coming years, growing to a value of $3.87 billion in 2029, at a compound annual growth rate (CAGR) of 13.0%. This projected growth for the forecast period can be linked to the rising demand for destination therapy, an aging population, an increase in healthcare spending, and heightened awareness about heart failure treatments. Key trends to watch include efforts to prolong the functional lifespan of VADs, reduction in VADs size, advancement in pump technologies, increased emphasis on VAD safety and efficacy, mitigation of VADs side effects, and the advent of percutaneously inserted ventricular assist devices.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6680&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Ventricular Assist Device Market?

Growth in the ventricular assist device market is being spurred by a rise in occurrence of cardiovascular ailments. Factors such as smoking, high cholesterol, high blood pressure, lack of physical activity, and more contribute to cardiovascular diseases. The surge in these diseases is also linked to noncommunicable conditions like diabetes, chronic respiratory diseases, and hypertension-induced heart attacks. As a crucial lifeline for critically sick heart patients, the demand for ventricular assist devices is anticipated to rise due to the upsurge in cardiovascular diseases. For example, forecasts from the National Library of Medicine, a federal agency in the U.S., indicate that by 2035, cardiovascular disease would affect 45.1% of the American population. Furthermore, the cumulative expenditure on cardiovascular diseases is expected to hit $1.1 trillion by 2035. As a result, the surge in cardiovascular disease rates is anticipated to fuel the demand for ventricular assist devices in the projected span.

Which Key Market Segments Comprise the Ventricular Assist Device Market and Drive Its Revenue Growth?

The ventricular assist devicemarket covered in this report is segmented –

1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs).

2) By Type: Pulsatile Flow, Continuous Flow

3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices

4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy

5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres

Subsegments:

1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs

2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs

3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=6680&type=smp

Which Areas Are Leading Regions in the Ventricular Assist Device Market Expansion Across the Globe?

North America was the largest region in the ventricular assist device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Strategic Trends Steering theVentricular Assist Device Market Direction?

The market is increasingly adopting ventricular assist devices that are inserted percutaneously. Such a device is a non-pulsatile axial flow pump, which is positioned across the aortic valve and enables the pumping of blood from the left ventricle. It helps reduce the burden on the left ventricle and the consumption of myocardial oxygen, thereby enhancing cardiac output and lowering left ventricular end-diastolic pressure. For instance, in August 2022, Abiomed Inc., a medical device company based in the US, rolled out Impella, a percutaneous VAD designed for qualified pediatric patients in the USA. This device offers adequate cardiac support to offset a defective left ventricle in patients and can either replace the extracorporeal membrane oxygenation (ECMO) or pair up with it to improve hemodynamics.

View the full report here:

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

How Is the Ventricular Assist Device Market Conceptually Defined?

A ventricular assist device refers to an implantable mechanical circulatory device used to treat heart failure by pumping blood from the heart to the rest of the body, improving circulation to vital organs. A wide range of ventricular assist devices are approved by the US FDA to provide long-term or permanent support to patients with end-stage heart failure.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6680

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model